
    
      A Single-Center,Open-Label,Randomized,Single-Dose,Two-Period,Two-Sequence,Crossover Study to
      Assess the Bioequivalence of Test Formulation Empagliflozin Tablets with Reference
      Formulation JardianceÂ® in Chinese Healthy Adult Subjects under Fasting and Fed Conditions.
    
  